Bexarotene

BreastfeedingPediatric
  • TRADE NAME: Targretin (Eisai)
  • INDICATIONS: Cutaneous T-cell lymphoma, mycosis fungoides
  • CLASS: Antineoplastic, Retinoid
  • HALF-LIFE: 7 hours

Retinoids can cause birth defects, and women should avoid bexarotene when pregnant or trying to conceive.

AVOID IN PREGNANCY

See full prescribing information for complete boxed warning.

Our database has 65 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 06/25/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top